EG24212A - Compositions of restricted cancer cells which produce cancer cell proliferation suppressive materials and uses thereof - Google Patents

Compositions of restricted cancer cells which produce cancer cell proliferation suppressive materials and uses thereof

Info

Publication number
EG24212A
EG24212A EG140099A EG140099A EG24212A EG 24212 A EG24212 A EG 24212A EG 140099 A EG140099 A EG 140099A EG 140099 A EG140099 A EG 140099A EG 24212 A EG24212 A EG 24212A
Authority
EG
Egypt
Prior art keywords
compositions
cell proliferation
restricted
cancer cell
produce
Prior art date
Application number
EG140099A
Other languages
English (en)
Inventor
Asina Shirin
Original Assignee
Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rogosin Inst filed Critical Rogosin Inst
Application granted granted Critical
Publication of EG24212A publication Critical patent/EG24212A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
EG140099A 1998-11-09 1999-11-08 Compositions of restricted cancer cells which produce cancer cell proliferation suppressive materials and uses thereof EG24212A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/188,476 US6224912B1 (en) 1996-04-03 1998-11-09 Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment

Publications (1)

Publication Number Publication Date
EG24212A true EG24212A (en) 2008-10-28

Family

ID=22693322

Family Applications (1)

Application Number Title Priority Date Filing Date
EG140099A EG24212A (en) 1998-11-09 1999-11-08 Compositions of restricted cancer cells which produce cancer cell proliferation suppressive materials and uses thereof

Country Status (19)

Country Link
US (4) US6224912B1 (ko)
EP (1) EP1128731B1 (ko)
JP (2) JP4294223B2 (ko)
KR (3) KR20050055797A (ko)
CN (1) CN1325271A (ko)
AT (1) ATE446678T1 (ko)
AU (1) AU769411B2 (ko)
CA (1) CA2334483C (ko)
DE (1) DE69941599D1 (ko)
DK (1) DK1128731T3 (ko)
EG (1) EG24212A (ko)
ES (1) ES2335723T3 (ko)
HK (1) HK1039439A1 (ko)
IL (3) IL139704A0 (ko)
NO (2) NO20012152L (ko)
NZ (1) NZ511220A (ko)
PT (1) PT1128731E (ko)
RU (2) RU2236855C2 (ko)
WO (1) WO2000027207A1 (ko)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39542E1 (en) * 1994-01-13 2007-04-03 The Rogosin Institute Preparation of agarose coated, solid agarose-collagen beads containing secretory cells
NZ278809A (en) * 1994-01-13 1998-03-25 Rogosin Inst Macroencapsulation of secretory cells in an agarose collagen gel material coated with agarose
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US7297331B2 (en) * 1996-04-03 2007-11-20 The Rogosin Institute Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
US20050053586A1 (en) 2003-09-04 2005-03-10 Bryan Conn Entrapped stem cells and uses thereof
US20060121077A1 (en) * 2004-11-11 2006-06-08 Lawrence Gazda Method for treating patients with implants of islets which have been kept in long term, in vitro culture
NZ566621A (en) * 2005-09-26 2010-07-30 Rogosin Inst Inc Agarose coated pancreas islets cells used for the treatment of insulin dependent diabetes
KR101491889B1 (ko) 2007-06-08 2015-02-11 하마마츠 포토닉스 가부시키가이샤 분광기
JP4887221B2 (ja) 2007-06-08 2012-02-29 浜松ホトニクス株式会社 分光モジュール
US8049887B2 (en) 2007-06-08 2011-11-01 Hamamatsu Photonics K.K. Spectroscopic module
US8045155B2 (en) 2007-06-08 2011-10-25 Hamamatsu Photonics K.K. Spectroscopic module
JP4891840B2 (ja) 2007-06-08 2012-03-07 浜松ホトニクス株式会社 分光モジュール
US8068223B2 (en) 2007-06-08 2011-11-29 Hamamatsu Photonics K.K. Spectroscopic module
JP4891841B2 (ja) 2007-06-08 2012-03-07 浜松ホトニクス株式会社 分光モジュール
EP2185730A4 (en) 2007-08-23 2010-10-27 Intrexon Corp METHOD AND COMPOSITIONS FOR SICKNESS DIAGNOSIS
JP2010540534A (ja) 2007-09-28 2010-12-24 イントレキソン コーポレーション 生体治療分子の発現のための治療遺伝子スイッチ構築物およびバイオリアクター、ならびにその使用
EP2801802A1 (en) 2008-03-04 2014-11-12 Hamamatsu Photonics K.K. Spectroscopy module
JP5205241B2 (ja) 2008-05-15 2013-06-05 浜松ホトニクス株式会社 分光モジュール
JP5205238B2 (ja) 2008-05-15 2013-06-05 浜松ホトニクス株式会社 分光モジュール
JP5415060B2 (ja) 2008-05-15 2014-02-12 浜松ホトニクス株式会社 分光モジュール
JP5205240B2 (ja) 2008-05-15 2013-06-05 浜松ホトニクス株式会社 分光モジュールの製造方法及び分光モジュール
JP2009300418A (ja) 2008-05-15 2009-12-24 Hamamatsu Photonics Kk 分光モジュール
JP5207938B2 (ja) 2008-05-15 2013-06-12 浜松ホトニクス株式会社 分光モジュール及び分光モジュールの製造方法
JP5512961B2 (ja) 2008-05-15 2014-06-04 浜松ホトニクス株式会社 分光モジュール及びその製造方法
EP2412800A1 (en) * 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
US8572921B2 (en) * 2009-03-27 2013-11-05 Davinci Roofscapes, Llc One piece hip and ridge shingle
CN109112097A (zh) * 2010-06-16 2019-01-01 米纳瓦生物技术公司 重编程癌细胞
US20120039955A1 (en) * 2010-08-12 2012-02-16 Janssen Biotech, Inc. Treatment of Diabetes with Pancreatic Endocrine Precursor Cells
WO2012071394A1 (en) * 2010-11-23 2012-05-31 The Rogosin Institute, Inc. Method for isolating a chemotherapeutic agent resistant cancer cell with stem cell properties
RU2591518C2 (ru) 2012-01-31 2016-07-20 Де Рогозин Инститьют Инк. Усовершенствованный способ получения макрогранул
EP3403098B1 (en) 2016-01-12 2021-09-22 BioAtla, Inc. Diagnostics using conditionally active antibodies
US10697972B2 (en) 2016-01-12 2020-06-30 Bioatla, Llc Diagnostics using conditionally active antibodies
KR200485213Y1 (ko) 2016-11-02 2017-12-07 고수한 높이 조절이 가능한 조립식평상
EP3746785A4 (en) * 2018-02-02 2022-05-11 Wake Forest University Health Sciences, Inc. IMMUNOTHERAPY RELATED ORGANOIDS AND METHODS OF PREPARING AND USING THEREOF

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865689A (en) 1972-11-09 1975-02-11 Hoffmann La Roche Method of producing carcinoembryonic antigens
US4285930A (en) 1977-12-08 1981-08-25 Likhite Vilas V Antigens comprising immunostimulant adjuvants and their use in immunotherapy
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4409331A (en) 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
US4391909A (en) 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
DE3032931C2 (de) 1980-09-02 1982-07-29 Robert Bürkle GmbH & Co, 7290 Freudenstadt Verfahren und Anordnung zur Herstellung von Mehrschicht-Leiterplatten
SE441009B (sv) 1982-03-08 1985-09-02 Kjell Nilsson Sett att immobilisera levande biomaterial i perlformiga polymerer
US4798786A (en) 1982-05-06 1989-01-17 Stolle Research And Development Corporation Living cells encapsulated in crosslinked protein
JPS5933223A (ja) 1982-08-20 1984-02-23 Koken Kk 人の悪性腫瘍細胞増殖抑制剤
CA1196862A (en) 1983-06-01 1985-11-19 Anthony M.F. Sun Microencapsulation of living tissue and cells
US4663286A (en) 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
US4680174A (en) 1984-05-24 1987-07-14 Damon Biotech, Inc. Induction of immune response by immunization with encapsulated antigen-producing cells
JPS6118721A (ja) 1984-07-06 1986-01-27 Kyowa Hakko Kogyo Co Ltd 新規抗腫瘍性物質
US4902295A (en) 1985-08-26 1990-02-20 Hana Biologics, Inc. Transplantable artificial tissue
US4997443A (en) 1985-08-26 1991-03-05 Hana Biologics, Inc. Transplantable artificial tissue and process
US5618715A (en) 1985-12-20 1997-04-08 Oncogen Limited Partnership Oncostatin M and novel compositions having anti-neoplastic activity
SE8604684L (sv) 1986-11-03 1988-05-04 Excorim Kommanditbolag Sett att belegga fasta partiklar med en hydrofil gel samt genom settet belagda partiklar
JPS6463395A (en) 1987-05-04 1989-03-09 Oncogen Oncostatin m and novel composition having antitumor activity
JPH0216994A (ja) 1988-07-05 1990-01-19 Nippon Mining Co Ltd 細胞増殖阻害因子及びその製造方法
US5053332A (en) 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
US5227298A (en) 1990-08-17 1993-07-13 The Trustees Of Columbia University In The City Of New York Method for microencapuslation of cells or tissue
US5800829A (en) 1991-04-25 1998-09-01 Brown University Research Foundation Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
ATE156344T1 (de) 1991-04-25 1997-08-15 Univ Brown Res Found Implantierbare, biokompatible immunisolator- trägersubstanz zum abgeben ausgesuchter, therapeutischer produkte
ZA939117B (en) * 1992-12-04 1994-08-05 Susanna Elizabeth Chalmers Pharmaceutical product
EP1179350A3 (en) 1993-08-12 2003-01-02 Cytotherapeutics, Inc. Encapsulated cell system for implantation into the human CNS
NZ278809A (en) * 1994-01-13 1998-03-25 Rogosin Inst Macroencapsulation of secretory cells in an agarose collagen gel material coated with agarose
ES2125630T3 (es) 1994-07-08 1999-03-01 Baxter Int Dispositivo implantable que contiene celulas tumorales, para el tratamiento del cancer.
US5888497A (en) * 1996-04-03 1999-03-30 The Rogosin Institute Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
CN1296477C (zh) 1996-04-03 2007-01-24 罗格森研究所 含有抑制癌细胞增殖的因子的条件培养基及其制备方法
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment

Also Published As

Publication number Publication date
US6808705B2 (en) 2004-10-26
IL139704A0 (en) 2002-02-10
EP1128731A4 (en) 2003-06-04
JP2005343899A (ja) 2005-12-15
AU769411B2 (en) 2004-01-29
IL177967A0 (en) 2006-12-31
AU1472600A (en) 2000-05-29
US20030143739A1 (en) 2003-07-31
EP1128731B1 (en) 2009-10-28
PT1128731E (pt) 2010-02-02
US20030143281A1 (en) 2003-07-31
RU2268735C1 (ru) 2006-01-27
WO2000027207A8 (en) 2000-09-21
EP1128731A1 (en) 2001-09-05
CN1325271A (zh) 2001-12-05
NO20101615L (no) 2001-07-05
DK1128731T3 (da) 2010-01-25
DE69941599D1 (de) 2009-12-10
CA2334483A1 (en) 2000-05-18
US6818230B2 (en) 2004-11-16
RU2004115040A (ru) 2005-10-27
JP2002529060A (ja) 2002-09-10
IL139704A (en) 2006-12-31
ATE446678T1 (de) 2009-11-15
HK1039439A1 (zh) 2002-04-26
JP4294223B2 (ja) 2009-07-08
IL177967A (en) 2010-12-30
RU2236855C2 (ru) 2004-09-27
US20020168415A1 (en) 2002-11-14
KR20050055797A (ko) 2005-06-13
ES2335723T3 (es) 2010-03-31
NO20012152D0 (no) 2001-05-02
US6224912B1 (en) 2001-05-01
CA2334483C (en) 2012-01-10
US7041504B2 (en) 2006-05-09
NZ511220A (en) 2003-12-19
WO2000027207A1 (en) 2000-05-18
KR20020013465A (ko) 2002-02-20
NO20012152L (no) 2001-07-05
KR20040075922A (ko) 2004-08-30

Similar Documents

Publication Publication Date Title
EG24212A (en) Compositions of restricted cancer cells which produce cancer cell proliferation suppressive materials and uses thereof
EP1024502A4 (en) ELECTROLYTE COMPOSITION, ELECTROLYTE AND METHOD FOR THE PRODUCTION THEREOF, AND THE CELL CONTAINING IT
BG102532A (en) Antifungal compositions with improved biological assimilation
AU3826999A (en) Compositions suitable for electrochemical cells
AU9592798A (en) Compositions containing an alpha1,2-fucose linkage and uses thereof
DE60138308D1 (de) Herstellung von feinkörnigen teilchen
NZ334034A (en) Use of a melanoma differentiation associated gene (mda-7) for reversing a cancerous phenotype
PL338338A1 (en) Controllable cytolysis of target cells, cytolysis causing media and composition as well as compound suitable for use in obtaining such media
FR2773807B1 (fr) Materiau cellulaire souple, composition et procede pour sa preparation
AU6505299A (en) Methods for generating antigen-reactive t cells (in vitro)
IL142720A (en) Water-miscible pharmaceutical compositions of paclitaxel
WO2002030465A3 (en) Compositions that inhibit proliferation of cancer cells
GB2345286B (en) Photoresist copolymer, process for preparing the same and photoresist composition comprising the same
DE59800439D1 (de) Vernetzbare, in Wasser redispergierbare Pulverzusammensetzung
MY124379A (en) Semiconductor component, in particular a solar cell, and process for manufacture of same
AU1337783A (en) New fibrionoltic enzymes
AU4859399A (en) Compositions and methods for treating papillomavirus-infected cells
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
NO943374D0 (no) Psylliumholdig materialsammensetning
AU8241498A (en) Electrochromic light-attenuation or -filtration device
GR3034675T3 (en) Polymer composition, the production and further processing thereof into receptacles
CA2369547A1 (en) Support material for the preparation of foodstuffs
NZ510584A (en) Methods and compositions for inhibiting neoplastic cell growth
AU4731599A (en) Material blend
AUPP706098A0 (en) Biological compositions, components thereof and uses therefor